Fresh Equities
ASX:CP1

ASX:CP1

CANNPAL ANIMAL THERAPEUTICS LIMITED

CANNPAL ANIMAL THERAPEUTICS LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Loading...


Company Overview

CannPal Animal Therapeutics Limited (CP1) is a pet pharmaceutical Company that has identified an opportunity to benefit from the rapidly growing medical cannabis sector, by developing standardised and dosage controlled, regulatory approved pharmaceuticals, derived from the cannabis plant. The Company is established to research, develop and commercialise regulatory approved, cannabinoid-derived therapeutics, for the global animal health markets, with an initial focus on cats and dogs, in the United States, Europe, Australia and other emerging global markets.

Type

Listed Company

GICS Sub-industry

Pharmaceuticals

Head Office

Level 3/43 Bay St, Double Bay NSW 2028, Australia

Pharmaceuticals
Health Care
Biotech & Health

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors

Fresh Equities does not have CANNPAL ANIMAL THERAPEUTICS LIMITED directors data.


Announcements

All
All Time
  • Quarterly Cash Flow Report & Market Update 31 Dec 2019 on 27 January 2020

    Commitments test entity quarterly reports

  • CannPal Enters into Exclusive Licencing Agreement with CSIRO on 5 January 2020

    Progress Report

  • Appendix 3B on 3 January 2020

    Issued Capital

    Change of Director's Interest Notice L Mills Updated on 9 December 2019

    Shareholder Details

    Change of Director's Interest Notice L Mills on 9 December 2019

    Shareholder Details

    Change of Director's Interest Notice L Mills on 5 December 2019

    Shareholder Details

    CannPal Removed from Restricted Securities List on 3 December 2019

    Progress Report

    CannPal Presents at Research Life Sciences Conference on 27 November 2019

    Progress Report

    Results of Annual General Meeting on 26 November 2019

    Notice Of Meeting

    Chairman's Address to Shareholders on 25 November 2019

    Chairman's Address

    Load More

News

Fresh Equities does not have CANNPAL ANIMAL THERAPEUTICS LIMITED news data.